Literature DB >> 15851765

Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status.

Carlos Bueso-Ramos1, Yunling Xu, Timothy J McDonnell, Shawn Brisbay, Sherry Pierce, Hagop Kantarjian, Gary Rosner, Guillermo Garcia-Manero.   

Abstract

PURPOSE: To study the relationship between protein expression and DNA methylation of a triad of cell-cycle regulatory genes known to be frequently methylated in adult acute lymphocytic leukemia (ALL). PATIENTS AND METHODS: Protein expression of p73, p15, and p57Kip2 was analyzed by immunohistochemistry using a tissue microarray (TMA) platform. The TMA was constructed using pretreatment bone marrow biopsy specimens from 64 adult patients with ALL. Protein expression was then correlated with DNA methylation and relevant clinical biologic characteristics.
RESULTS: p73 protein expression was observed in 19 (30%) patients, cytoplasmic p15 in 19 (31%), and p57 in 40 (70%). Three patients (5%) had expression of all three proteins, 16 (29%) of two proteins, 31 (55%) of one protein, and six (11%) of zero proteins. An inverse association was observed between p73 DNA methylation and protein expression (P = .003). This effect was not observed for either p15 or p57Kip2. Expression of any of the proteins studied was not associated with any distinct biologic characteristic. By multivariate analysis, expression of p57Kip2, cytoplasmic p15, or a combination of p57Kip2 with either p15 or p73 was associated with a better overall survival (P < .001, .04, and .03 respectively).
CONCLUSION: Expression of a triad of cell cycle regulatory proteins that includes p73, p15, and p57Kip2 has prognostic value in adult patients with ALL independently of the methylation status of each gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851765     DOI: 10.1200/JCO.2005.02.998

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  12 in total

1.  Tissue microarray technique is applicable to bone marrow biopsies of myeloproliferative neoplasms.

Authors:  Kathrin A Limberger; Lioudmila Bogatyreva; Rumyana Todorova; Bettina Herde; Dieter Hauschke; Heike L Pahl; Martin Werner; Konrad Aumann
Journal:  Histochem Cell Biol       Date:  2016-08-20       Impact factor: 4.304

2.  Construction and validation of a bone marrow tissue microarray.

Authors:  Annette Zimpfer; Sharon Schönberg; Alessandro Lugli; Claudio Agostinelli; Stefano A Pileri; Philip Went; Stephan Dirnhofer
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

Review 3.  Pharmacotherapeutic advances in the treatment of acute lymphoblastic leukaemia in adults.

Authors:  Mark R Litzow
Journal:  Drugs       Date:  2011-03-05       Impact factor: 9.546

4.  DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia.

Authors:  W S Stevenson; O G Best; A Przybylla; Q Chen; N Singh; M Koleth; S Pierce; T Kennedy; W Tong; S-Q Kuang; G Garcia-Manero
Journal:  Leukemia       Date:  2013-09-18       Impact factor: 11.528

5.  A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis.

Authors:  A Quintás-Cardama; W Tong; H Kantarjian; D Thomas; F Ravandi; S Kornblau; T Manshouri; J E Cortes; G Garcia-Manero; S Verstovsek
Journal:  Leukemia       Date:  2008-04-03       Impact factor: 11.528

6.  Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells.

Authors:  Huibo Li; Xiaolin Kong; Gang Cui; Cuicui Ren; Shengjin Fan; Lili Sun; Yingjie Zhang; Rongyi Cao; Yinghua Li; Jin Zhou
Journal:  Int J Hematol       Date:  2015-09-11       Impact factor: 2.490

7.  Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia.

Authors:  Hui Yang; Tapan Kadia; Lianchun Xiao; Carlos E Bueso-Ramos; Koyu Hoshino; Deborah Ann Thomas; Susan O'Brien; Elias Jabbour; Sherry Pierce; Gary L Rosner; Hagop M Kantarjian; Guillermo Garcia-Manero
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

Review 8.  Epigenetics of acute lymphocytic leukemia.

Authors:  Guillermo Garcia-Manero; Hui Yang; Shao-Qing Kuang; Susan O'Brien; Deborah Thomas; Hagop Kantarjian
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

9.  Drug targets for cell cycle dysregulators in leukemogenesis: in silico docking studies.

Authors:  Archana Jayaraman; Kaiser Jamil
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 10.  The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia.

Authors:  Celia González-Gil; Jordi Ribera; Josep Maria Ribera; Eulàlia Genescà
Journal:  Genes (Basel)       Date:  2021-01-09       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.